pros and cons of glp-1 agonist Your guide to side effects What should you do when
Description
Increased risk of atrial fibrillation and stroke during active stages of inflammatory bowel disease: a nationwide study
Highlights of Prescribing Information FOUNDAYO
Pemvidutide from Altimmune is another dual GLP-1/glucagon agonist with particular promise for liver disease
Gastroenterol Res Pract
MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study
